Concurrent Enumeration of CD34+ and CD3+ Cells in Allogeneic Apheresis Collections

Concurrent Enumeration of CD34+ and CD3+ Cells in Allogeneic Apheresis Collections Using a New Flow Cytometry Method

Authors: Elaine Than2, Yesmin Chowdhury1, Alla Oren1, Rehana Clouden1, Marina Zlotina1, Felix Montero-Julian2, Hemant Raj Joshi1, Wei Cai1, Ahmad Al-Attar3, Gal Gabay2 and Yossef Vasilevski2, Amanda Trent2 and Camelia Iancu-Rubin1
1Icahn School of Medicine and Mount Sinai Hospital, Mount Sinai Health System, New York, NY, USA; 2Accellix, Inc. San Jose, CA, USA; 3University of Pittsburgh, Pittsburgh, PA, USA
ISCT 2026 | May 6 – 9 | Dublin, Ireland

Description: Donor lymphocyte infusions (DLI) are commonly used to prevent or treat relapse after allogeneic stem cell transplantation. DLIs may be collected through a separate apheresis procedure or derived from excess mobilized stem cell grafts. The latter approach is routine at our institution and requires quantification of both CD34+ stem/progenitor cells and CD3+ T lymphocytes. Currently, these measurements are performed in two separate assays by an independent laboratory. Here, we evaluated a new flow cytometry method that enables in-house simultaneous enumeration of CD34+ and CD3+ cells in a single assay with the potential to streamline graft characterization, reduce turnaround time, and decrease resource utilization.

Provide the following information and we’ll email you a copy of the poster:

*Required field

    Interest*